Learn More
Invitrogen™ PRP19 Polyclonal Antibody

Description
Recommended positive controls: 293T, A431, H1299, HeLaS3, HepG2, Molt-4, Raji. Predicted reactivity: Mouse (100%), Rat (100%), Xenopus laevis (83%), Pig (99%), Chicken (98%), Rhesus Monkey (100%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | PRP19 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1.04 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 |
| Gene | Prpf19 |
| Gene Accession No. | Q9UMS4 |
| Gene Alias | AA617263; AL024362; D19Wsu55e; hPSO4; Neuronal differentiation-related gene protein; NMP200; Nuclear matrix protein 200; nuclear matrix protein NMP200 related to splicing factor PRP19; nuclear matrix protein SNEV; pre-mRNA processing factor 19; pre-mRNA-processing factor 19; PRP19; prp19 beta; PRP19/PSO4 homolog; PRP19/PSO4 pre-mRNA processing factor 19 homolog; PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae); PRPF19; PSO4; psoralen 4; RING-type E3 ubiquitin transferase PRP19; Senescence evasion factor; SNEV; UBOX4 |
| Gene Symbols | Prpf19 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.